Carregant...
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters
INTRODUCTION: Benefits of disease-modifying anti-rheumatic drugs (DMARD) in early rheumatoid arthritis patients (ERAP) will be achieved if patients follow prescribed treatment. Objective was to investigate whether timing of first non-persistence period and/or duration of persistence during the first...
Guardat en:
| Publicat a: | Arthritis Res Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4499189/ https://ncbi.nlm.nih.gov/pubmed/26162892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0697-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|